Market Summary: In 2022, the global market size for rheumatoid arthritis drugs was USD 24.89 billion, projected to reach USD 38.61 billion by 2032, with a forecasted revenue CAGR of 5%. Rheumatoid arthritis, a chronic autoimmune disease affecting joints and causing swelling, discomfort, is increasingly prevalent globally, impacting approximately 1.3 million people in the U.S. […]